Pharma Voice Magazine features Sandra Shpilberg from Seeker Health, an EVERSANA company, in their March 2019 issue. The topic is “Wearables in Clinical Trial”. 
The article discusses how wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies. And experts agree: future drug development will be based on broader, real-time patient data.
Click here to read the full article on pharmavoice.com.
Author
Sandra Shpilberg
Managing Director
Sandra’s entrepreneurial spirit and experience in the pharma and biopharmaceutical industries led her to develop a breakthrough digital patient identification technology designed to accelerate drug development and commercialization for biopharmaceutical companies. The product currently serves more than 40 companies in helping to accelerate clinical trial enrollment in rare diseases and oncology. Medical Marketing & Media […]
Author
Sandra Shpilberg
Managing Director
Sandra’s entrepreneurial spirit and experience in the pharma and biopharmaceutical industries led her to develop a breakthrough digital patient identification technology designed to accelerate drug development and commercialization for biopharmaceutical companies. The product currently serves more than 40 companies in helping to accelerate clinical trial enrollment in rare diseases and oncology. Medical Marketing & Media […]